Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP21 pseudogene 1 (USP21P1) is not a well-characterized or canonical protein-coding target; it is a pseudogene related to the well-known human gene ubiquitin specific peptidase 21 (USP21), but does not produce a functional protein product[5]. There is little to no evidence supporting a biological function, molecular activity, or therapeutic role for USP21P1, in contrast to USP21. The information below is provided to clarify the context and point out the distinction. USP21 pseudogene 1 (USP21P1) is a genomic sequence that closely resembles the human USP21 gene but is classified as a pseudogene[5]. Pseudogenes, by definition, typically do not encode functional proteins and do not carry out biological roles or therapeutic functions. USP21P1 does not share the enzymatic activities, biological functions, or disease relevance attributed to USP21. If your intention was the protein-coding gene USP21, this should be corrected to "ubiquitin specific peptidase 21 (USP21)," which is an active deubiquitinating enzyme implicated in cellular homeostasis, cancer, immune regulation, and more[1][2][3][4][5]. There is no evidence that USP21P1 is considered a therapeutic target, nor does it have associated drugs, mechanism of action, biomarker utility, or reported safety concerns. This entry appears to be incorrect for most drug discovery, target identification, or biological function purposes. If you intended to refer to USP21 (the enzyme), see entries under "ubiquitin specific peptidase 21" or "USP21." If you need information on the true functional gene USP21, let me know and I can provide detailed actionable data on its biochemical role, disease relevance, therapeutic targeting, and related context[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP21 pseudogene 1 (USP21P1).